Skip to main content

. 1959 May 30;1(5134):1387–1389. doi: 10.1136/bmj.1.5134.1387

Disturbances of Pigmentation with Chloroquine

John L C Dall, Julia A Keane

PMCID: PMC1993594 PMID: 13651742

1387

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BAGNALL A. W. The value of chloroquine in rheumatoid disease: a four-year study of continuous therapy. Can Med Assoc J. 1957 Aug 1;77(3):182–194. [PMC free article] [PubMed] [Google Scholar]
FULD H., HORWICH L. Treatment of rheumatoid arthritis with chloroquine. Br Med J. 1958 Nov 15;2(5106):1199–1201. doi: 10.1136/bmj.2.5106.1199. [DOI] [PMC free article] [PubMed] [Google Scholar]
HOBBS H. E., CALNAN C. D. The ocular complications of chloroquine therapy. Lancet. 1958 Jun 7;1(7032):1207–1209. doi: 10.1016/s0140-6736(58)91911-1. [DOI] [PubMed] [Google Scholar]
PAGE F. Treatment of lupus erythematosus with mepacrine. Lancet. 1951 Oct 27;2(6687):755–758. doi: 10.1016/s0140-6736(51)91643-1. [DOI] [PubMed] [Google Scholar]
TYE M. J., SCHIFF B. L., COLLINS S. F., BALER G. R., APPEL B. Chronic discoid lupus erythematosus: treatment with daraprim and chloroquine diphosphate (aralen). N Engl J Med. 1954 Jul 8;251(2):52–55. doi: 10.1056/NEJM195407082510202. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES